FIELD: medicine. SUBSTANCE: method involves administering Ethymizol at a daily dose of 0.3-0.8 g for 10-30 days after having determined in advance diurnal morning and evening serum cortisol level and the value occurred to be lower than the physiological level. EFFECT: enhanced effectiveness of treatment; stable clinical remission; reduced drug consumption; avoided abstinence syndrome occurrence.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING COMPLICATIONS IN PATIENTS WITH CHRONIC NONSPECIFIC ULCERATIVE COLITIS | 2015 |
|
RU2607160C2 |
METHOD FOR DIAGNOSING DISTURBED BRONCHIAL PATENCY | 1998 |
|
RU2160045C2 |
METHOD TO CORRECT LIPID PEROXIDE OXIDATION IN PATIENTS SUFFERING ISCHEMIC CARDIAC DISEASE | 1999 |
|
RU2178704C2 |
METHOD FOR TREATING CHRONIC PERIODONTITIS | 1999 |
|
RU2161920C1 |
SURGICAL METHOD FOR TREATING THE CASES OF ACQUIRED TRACHEO- ESOPHAGEAL FISTULAS | 2000 |
|
RU2202961C2 |
METHOD FOR PREPARING SKIN COVER DEFECT TO AUTODERMOPLASTY OPERATION | 2000 |
|
RU2192266C2 |
DRAINING DEVICE | 1999 |
|
RU2160126C1 |
METHOD FOR DIAGNOSING FOCAL SPLEEN LESIONS | 2000 |
|
RU2190959C2 |
METHOD FOR EVALUATING FUNCTIONAL STATE OF THE SPLEEN | 1999 |
|
RU2152168C1 |
METHOD OF DETERMINING INDICATIONS FOR PERFORMING EFFERENT THERAPY | 1996 |
|
RU2163018C2 |
Authors
Dates
2003-03-10—Published
1999-03-05—Filed